患者驱动的罕见疾病研究网络:颠覆研究
Jo Balfour1, Laura B Cowley2,3, Georgina Windsor4,5
1Cambridge Rare Disease Network, Cambridge, UK.
BMJ open
|October 27, 2025
概括
罕见疾病研究网络 (RDRN) 赋予患者领导研究的权力,解决罕见疾病的未满足需求. 这个网络促进了合作,推动了以患者为中心的研究和改善结果.
科学领域:
- 罕见疾病研究研究.
- 患者和公众参与.
- 健康研究创新健康研究创新
背景情况:
- 研究人员主导的研究往往与患者的优先事项不一致,特别是在治疗选择有限的罕见疾病中.
- 患有罕见病的人面临着巨大的未满足的身体,精神和情感需求.
- 现有的患者和公众参与 (PPI) 资源主要支持研究人员,而不是患者主导的倡议.
研究的目的:
- 介绍罕见疾病研究网络 (RDRN),这是一个新的患者主导的协作平台.
- 突出RDRN在支持患者驱动和联合制作的研究中的作用.
- 展示RDRN在调整研究与患者优先事项和能力建设方面的潜力.
主要方法:
- 该RDRN与罕见疾病社区共同制作,包括患者,家长,护理人员和倡导者.
- 它作为一个开放的协作平台,将有共同研究兴趣的合作伙伴联系起来.
- 该网络得到学术和研究机构的支持,以消除参与障碍.
主要成果:
- RDRN为罕见病社区提供了一个结构化的途径,以贡献他们的经验和见解.
- 它使患者能够成为"研究准备",从研究开始就积极参与研究.
- 该网络促进了新的伙伴关系,并支持上游协作,推动有影响力的研究.
结论:
- RDRN为罕见病研究提供了一种新的,患者向外的方法,与现实世界的需求保持一致.
- 它有可能成为共同设计的罕见病研究的可扩展模型,推动有意义的变化.
- 通过建立信任和能力,RDRN支持英国罕见病框架的发现和改善结果的目标.
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397


